Navigation Links
Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Date:1/3/2012

AMSTERDAM, January 4, 2012 /PRNewswire/ --

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its gene therapy program for the treatment of hemophilia B. Orphan designation in the U.S. could provide up to seven years market exclusivity on regulatory approval. Orphan designation for AMT's hemophilia program in the European Union was granted in November 2011.

AMT's hemophilia B program, which consists of an adeno-associated viral (AAV) vector containing the human factor IX gene, is being investigated in a Phase I/II study conducted by St. Jude's Children's Research Hospital (Memphis, USA) and University College London (UK). Promising data from an initial 6 patients, recently published in the New England Journal of Medicine (N Engl J Med 2011; 365:2357-2365), shows that gene therapy administration resulted in a reduced need for protein replacement treatment, the standard care for hemophilia patients.  AMT is preparing for additional clinical development work to establish safety, tolerability and proof-of-concept with a factor IX gene therapy produced using its proprietary AAV production system.

"U.S. orphan designation provides additional support for our hemophilia B gene therapy program and supplements the designation in the EU received in November," said Jörn Aldag, CEO of AMT. "The early clinical success seen with the program to date by our partners is very encouraging. We will build on this success in the coming months."  

About Amsterdam Molecular Therapeutics

AMT is a world leader in the development of human gene based therapies. AMT has a product pipeline of gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. Using adeno-associated viral (AAV) derived vectors as the delivery vehicl
'/>"/>

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
2. Amsterdam Molecular Therapeutics Reports Full Year Results 2008
3. Amsterdam Molecular Therapeutics Reports Half Year Results 2009
4. The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project
5. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
6. Amsterdam Molecular Therapeutics Reports Half-Year Results 2010
7. Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
8. Amsterdam Molecular Therapeutics Appoints Dr. Carlos R. Camozzi as Chief Medical Officer
9. Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination
10. Amsterdam Molecular Therapeutics Reports Half-Year Results 2011
11. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... particularly ingenious when it comes to survival strategies. They ... hostile environment, for example during treatment with antibiotics. A ... a protective slime capsule consisting of sugar chains and ... have for the first time created a detailed three-dimensional ... blocks cross the bacterial cell wall, a crucial step ...
(Date:9/12/2014)... -- Research and Markets has announced the ... Report 2014" report to their offering. ... is a professional and in-depth study on the current ... The report provides a basic overview of ... structure. The dry film photoresist market analysis is provided ...
(Date:9/11/2014)... cells (hiPSCs), researchers have gained new insight into ... patterns of neuronal signaling associated with this disease. ... the hiPSCs of healthy individuals and of patients ... stem cells to release neurotransmitters, such as dopamine, ... linked to various disorders. By discovering a simple ...
(Date:9/11/2014)... , Sept. 11, 2014 XBiotech announced ... throughput filling machine that the Company says will be ... fully integrated system is designed to fill, stopper and ... manufacturing process. Additionally, the unit is said to contain ... system to provide a high level of quality compared ...
Breaking Biology Technology:New insights in survival strategies of bacteria 2Global Dry Film Photoresist Industry Report 2014 2Stem cells help researchers understand how schizophrenic brains function 2
... A key lawmaker who often disagrees with Governor ... he saw nothing inappropriate about the governor's use of an ... stem cell companies. , ,Meanwhile, the executive order, signed Tuesday ... from the director of Pro Life Wisconsin. , ,Ted Kanavas, ...
... - The Wisconsin Department of Motor Vehicles has deployed ... out of crime. , ,Preventing mischief in the issuance of ... Alioto, a fraud prevention specialist with the DMV , ... like a Social Security card or a birth certificate, a ...
... you're not reading this column, at least not today. May ... on the planet of the contributions to society and economy ... thousands of people will take to the streets in support ... will stay home from work. Some plan to keep their ...
Cached Biology Technology:Republican sees nothing wrong with Doyle's use of executive order 2New DMV tool never forgets a face 2New DMV tool never forgets a face 3Technology and the "American" dream 2
(Date:9/15/2014)... When this week,s print issue of the journal ... up from New Mexico, Montana and even the Netherlands, ... more and more the norm in these connected times. ... it will produce innovations in biology, medicine, biotechnology and ... this scientist talked with that one, that one knew ...
(Date:9/15/2014)... Sonja Schmid, an assistant professor in the Department of ... Liberal Arts and Human Sciences at Virginia Tech, has ... (CAREER) Award to study the prospects and problems of ... catastrophic failure of Japan,s Fukushima I Nuclear Power Plant ... the scientific community viewed nuclear emergencies, Schmid said. Three ...
(Date:9/15/2014)... wild, domesticated, and domesticated-wild hybridized populations of ... that within 5 to 11 generations, selection ... populations that hybridized with domesticated populations. , ... evidence that natural selection, over time, removes ... as a result of increased genetic diversity. ...
Breaking Biology News(10 mins):Collaboration drives achievement in protein structure research 2'Nuclear disasters don't respect national boundaries' 2
... to local climates -- and potentially to climate change -- may ... to new research published in Science by UBC evolutionary ... resistance to local pests -- that has helped purple loosestrife to ... species to rapidly adapt to local climate has not generally been ...
... been invading Europe,s rivers and lakes for several decades, but ... and problematic, like so many other invaders - such as ... European shrimps have something to do with this? Jaimie ... and found it only existed where native shrimps were absent ...
... body of water, from a puddle or a pond to ... rocks, plants, and animals. These so-called sessile suspension feeders are ... cleaning up environmental contaminants by consuming bacteria. A study published ... Journal reveals that by actively changing the angle of ...
Cached Biology News:Adaptability to local climate helps invasive species thrive 2Predators vs. alien: European shrimps win predatory battles with an American invader 2How tiny organisms make a big impact on clean water 2
Request Info...
Request Info...
FITC~Bovine Serum Albumin...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Biology Products: